Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Thermo Fisher Scientific Showcases Expanded Offering for Clinical Laboratory

By Labmedica International staff writers
Posted on 29 Jul 2014
Print article
Image: Customers in clinical laboratories supporting hospitals, research institutions and government agencies are increasingly relying on ThermoFisher Scientific to achieve better diagnostics, improve patient care, and lower costs (Photo courtesy of Thermo Fisher Scientific).
Image: Customers in clinical laboratories supporting hospitals, research institutions and government agencies are increasingly relying on ThermoFisher Scientific to achieve better diagnostics, improve patient care, and lower costs (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) is introducing its Thermo Scientific and Life Technologies (Grand Island, NY, USA) products at the 2014 AACC Annual Meeting and Clinical Lab Expo. Thermo Fisher Scientific Inc. is highlighting its expanded portfolio of instruments, equipment, consumables, and software, for improving accuracy and efficiency in the clinical laboratory.

Marc N. Casper, president and CEO of Thermo Fisher Scientific comments “In the current healthcare environment, our customers in clinical laboratories supporting hospitals, research institutions, and government agencies are increasingly relying on better diagnostics to improve patient care and lower costs. We have the scale and depth of capabilities to help these customers drive accuracy and efficiency and ultimately improve the way healthcare is delivered.”

At AACC, Thermo Fisher will feature a range of products and services from its specialty diagnostics, analytical instrument, and genetic analysis portfolios including complete systems for aiding in the diagnosis of allergy and autoimmune diseases using ImmunoCAP and EliA blood tests such as the DRI Drugs of Abuse Assays, immunosuppressant assays, the CEDIA Cyclosporine Immunoassay, and the QMS Everolimus Immunoassay for therapeutic drug monitoring.

Next-generation sequencing platforms, including the Ion Torrent Personal Genome Machine and the Ion Chef automated sample preparation system for identifying genetic biomarkers of disease are also being shown. A new category of Thermo Scientific products, including high-performance liquid chromatography, mass spectrometry, and software designed and manufactured as US Food and Drug Association (FDA) Class 1 medical devices for use in laboratory-developed tests, and Thermo Scientific calibration and quality controls. In addition, the MAS LabLink Quality Assurance Program, a cloud-based application that offers an external perspective on daily QC and compares the data among peer laboratories will be revealed. Services including original equipment manufacturer (OEM) and custom services for development, manufacturing, and packaging of diagnostic products for third parties, as well as collaborative biomarker research and production services for industry and academia through the Thermo Fisher BRIMS center are introduced.

For a complete listing of products and services being showcased during AACC, please visit Thermo Fisher Scientific online (Please see Related Links below).

Related Links:

Thermo Fisher Scientific
Life Technologies



Print article

Channels

Genetic Tests

view channel
Image: The BioMek FXP automation workstation (Photo courtesy of Beckman Coulter).

Innovative Gene Testing Technology Finds Cancer Risks

A new method has been developed for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate,... Read more

Industry News

view channel

Luminex Enters Agreement to Acquire Nanosphere

Luminex Corporation (Austin, TX, USA) and Nanosphere, Inc. (Northbrook, IL, USA) have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in molecular microbiology and diagnostics, in an all-cash transaction valued at approximately USD 77 million (USD 1.70 per share).... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.